Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling
about
Monosodium glutamate-induced oxidative kidney damage and possible mechanisms: a mini-reviewGlutamate and tumor-associated epilepsy: glial cell dysfunction in the peritumoral environmentMST3 kinase phosphorylates TAO1/2 to enable Myosin Va function in promoting spine synapse developmentAltered serine/threonine kinase activity in schizophreniaReduction in phencyclidine induced sensorimotor gating deficits in the rat following increased system xc⁻ activity in the medial prefrontal cortex.Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture.Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity.Glutamate as a neurotransmitter in the healthy brainLocalization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: a light and electron microscopic studyChange of cystine/glutamate antiporter expression in ethanol-dependent rats.Behavioral assessment of acute inhibition of system xc (-) in ratsRedox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?Redox-based therapeutics in neurodegenerative disease.Aggrecan and chondroitin-6-sulfate abnormalities in schizophrenia and bipolar disorder: a postmortem study on the amygdalaN-acetyl-cysteine, a drug that enhances the endogenous activation of group-II metabotropic glutamate receptors, inhibits nociceptive transmission in humans.Thiol redox homeostasis in neurodegenerative diseaseGlutamate transporter GLT-1 mediates N-acetylcysteine inhibition of cocaine reinstatement.Effects of ceftriaxone on GLT1 isoforms, xCT and associated signaling pathways in P rats exposed to ethanol.Ceftriaxone attenuates acquisition and facilitates extinction of cocaine-induced suppression of saccharin intake in C57BL/6J miceA Cytotoxic, Co-operative Interaction Between Energy Deprivation and Glutamate Release From System xc- Mediates Aglycemic Neuronal Cell DeathInterleukin 1β Regulation of the System xc- Substrate-specific Subunit, xCT, in Primary Mouse Astrocytes Involves the RNA-binding Protein HuRAbnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophreniaPituitary Adenylate cyclase-activating polypeptide orchestrates neuronal regulation of the astrocytic glutamate-releasing mechanism system xc (.).N-acetylcysteine decreases binge eating in a rodent modelAbsence of system xc- on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis.Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapseNeurotransmitter signaling in the pathophysiology of microglia.Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach.N-Acetylcysteine and metabotropic glutamate receptors: implications for the treatment of schizophrenia: a literature review.Glutamate receptors in the kidney.Microwave accelerated synthesis of isoxazole hydrazide inhibitors of the system xc- transporter: Initial homology modelMain path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission.Permanent dynamic transporter-mediated turnover of glutamate across the plasma membrane of presynaptic nerve terminals: arguments in favor and against.Emerging roles of system [Formula: see text] antiporter and its inhibition in CNS disorders.Metabolomics reveals distinct neurochemical profiles associated with stress resilience.Accumbens Mechanisms for Cued Sucrose Seeking.The good and bad news about glutamate in drug addiction.l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?Parkinson's disease: Microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegenerationComparative analysis of antibodies to xCT (Slc7a11): Forewarned is forearmed.
P2860
Q26780337-B9F63AF6-71F8-4893-BAE0-656FB854AC02Q27011499-337D6B29-3A63-4717-ADA6-9A1ABBFE3096Q28582874-FB42C0F5-72BD-4AF2-BFD0-9C385853ACF9Q30409979-E09AD627-E317-4F66-8753-0164FD60A106Q30440988-368233B7-AD15-4227-95C6-E6388D13A314Q33709279-DEC80F28-7A8A-4B12-9CF4-0AC3DBCB33B8Q33898352-B556054C-27E7-474E-9850-970589369A1CQ34048502-54AC8213-D36E-47BA-B3D5-EF206D33F669Q34184026-0F42A6F0-3F14-487D-AA4F-0D3C450CA4FBQ34292046-18830BF7-987D-4EA7-9656-25B8CF5BD614Q34420036-F161E3DE-432B-4A26-B140-654155739F7BQ34428194-15CD3616-AA88-4E3C-852F-7CFC991F165DQ34535918-CEFA35A1-E209-4A58-9982-491AE1B2B554Q35034774-AD28C92E-AD22-42A3-A7DA-FC91FE59EDA6Q35232882-ED97BBA2-A8EF-4066-81DA-07AE7F6227D5Q35614227-538EDA5B-A014-4BFC-BBED-D061981078CEQ35623912-40DE0438-E545-49BE-B4E6-87A3E5C7E3C7Q35738010-6947605E-DD3E-4B1A-B73D-AE7AB82D0D25Q35864748-84D9C812-7249-4545-9233-DE0F88A6D24DQ36271038-C20ED061-1651-433A-9B11-A13CB2D5E978Q36489257-43D750BB-8880-4E11-A997-632DECE29B6FQ36609289-C2BE11E0-9866-4B3B-9594-58BCBE763364Q36930072-9933701D-988D-4993-89D6-7A45DE5BBAC6Q37072055-9E647C86-E433-4D13-A0C0-120C10FF8ACAQ37586538-628B833C-56CB-4973-A479-56C65AB0683CQ37705513-0336A24F-6F1C-4ABF-A5BC-2BC1CFBC6D5FQ38102686-C2A1C86D-0C3F-4CBC-9C7E-7CCE7EFEA4A6Q38154625-FD8DEA81-8E29-40C0-9BFE-8CD1C55E9ADFQ38175882-40BCFB09-7D96-43BB-ACAE-5E9F86571DA2Q38398618-96CEC438-FC66-45EE-87F6-3BFB7AE10106Q38452842-EB6D9383-F604-4152-8BD7-69BD3ED38D85Q38580123-198C1CD6-1E9B-4DBC-A696-BF414F092640Q38583424-2068C0E9-840C-4993-9462-C2DB05B5EBA4Q38618048-D6EF953F-564E-4721-B98A-CE992C9AEAC1Q38638954-2170CCFD-A2F9-4A81-AFE5-5583F4EA5337Q38670605-C5BAFDA1-30B9-43EF-BA10-E67089A6C4FBQ38879815-2C6E5D7B-3F53-42A9-8322-6250D3D87C3AQ39012371-BB0AC3B7-5DE7-4815-BE8F-ADE8654A8800Q39327711-856F93E5-C352-4E49-9ACD-81D4C5CBC8EAQ40400682-1431B6D7-CBE2-4E57-88FF-B0A93EE3A985
P2860
Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Thinking outside the cleft to ...... ogical glutamatergic signaling
@ast
Thinking outside the cleft to ...... ogical glutamatergic signaling
@en
Thinking outside the cleft to ...... ogical glutamatergic signaling
@nl
type
label
Thinking outside the cleft to ...... ogical glutamatergic signaling
@ast
Thinking outside the cleft to ...... ogical glutamatergic signaling
@en
Thinking outside the cleft to ...... ogical glutamatergic signaling
@nl
prefLabel
Thinking outside the cleft to ...... ogical glutamatergic signaling
@ast
Thinking outside the cleft to ...... ogical glutamatergic signaling
@en
Thinking outside the cleft to ...... ogical glutamatergic signaling
@nl
P2093
P2860
P356
P1476
Thinking outside the cleft to ...... ogical glutamatergic signaling
@en
P2093
Doug Lobner
Richard Bridges
Victoria Lutgen
P2860
P304
P356
10.1124/PR.110.003889
P407
P577
2012-07-01T00:00:00Z